Marco Mellado

Dr. Marco Mellado

Universidad Central de Chile, Santiago, Región Metropolitana, Chile
orcid
Centro de Investigación en Ingeniería de Materiales y Grupo ...

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2019 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
MMMarco Mellado
Marco Mellado
LELuis Espinoza
Luis Espinoza
AMAlejandro Madrid
Alejandro Madrid
JMJaime Mella
Jaime Mella
ECEduardo Chávez-Weisser
Eduardo Chávez-Weisser
MCMauricio Cuellar
Mauricio Cuellar

1 March 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MMMarco Mellado
Marco Mellado
CGCésar González
César González
JMJaime Mella
Jaime Mella
LALuis F. Aguilar
Luis F. Aguilar
DVDolores Viña
Dolores Viña
MMMaria Matos
Maria Matos

28 April 2022 in ACS Omega
Verified
Journal Article
Open access
UÇUlviye Acar Çevik
Ulviye Acar Çevik
ICIsmail Celik
Ismail Celik
JMJaime Mella
Jaime Mella
MMMarco Mellado
Marco Mellado
YÖYusuf Özkay
Yusuf Özkay
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
In this study, a series of novel 1,3,4-oxadiazole-benzimidazole derivatives were designed and synthesized. Their cytotoxic activities against five cancer cell lines, including A549, MCF-7, C6, HepG2, and HeLa, were evaluated by the MTT assay. The compounds 5b,c showed satisfactory potencies with much higher anticancer activity in comparison to the reference drug doxorubicin against the studied cancer cell lines. In vitro, enzymatic inhibition assays of aromatase (ARO) enzymes were performed. Molecular docking, molecular dynamics simulations, and binding free energy analyses were used to better understand the structure-activity connections and mechanism of action of the aromatase inhibitors. Two types of satisfactory 3D-QSAR (CoMFA and CoMSIA) models were generated, to predict the inhibitory activities of the novel inhibitors. Molecular docking studies were also carried out to find their binding sites and types of their interactions with the aromatase enzyme. Additionally, molecular dynamics simulations were performed to explore the most likely binding modes of compounds 5b,c with CYP19A1.

4 March 2019 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MMMarco Mellado
Marco Mellado
MSMauricio Soto
Mauricio Soto
AMAlejandro Madrid
Alejandro Madrid
IMIván Montenegro
Iván Montenegro
CGCarlos Esteba Jara Gutiérrez
Carlos Esteba Jara Gutiérrez
LALuis F. Aguilar
Luis F. Aguilar
Ephedra chilensis K Presl, known locally as pingo–pingo, is a Chilean endemic plant used in traditional medicine as an anti-inflammatory and used in other treatments. However, unlike for the other Ephedra species, there have been no reports on the antioxidant and cytotoxic effects of this plant. The present study aims to explore the potential applications of E. chilensis extract as a cytotoxic agent against in vitro cancer cell lines and to explore the relationship between this extract and antioxidant activity. Total anthraquinone, flavonoid, and phenolic contents, as well as antioxidant activity (DPPH, FRAP, and TRAP assays) and cytotoxic effect on several cancer cell lines (MCF-7, PC-3, DU-145, and HT-29) were measured for the hexane, dichloromethane and ethanol extracts of E. chilensis. In addition, several correlations among the phytochemical content, antioxidant activity, and cytotoxic effect were evaluated. Finally, GC-MS analyses of the most active extracts were carried out to identify their major components and to relate these components to the cytotoxic effect. Antioxidant activity was found in the EtOH extracts of Ephedra, and the results were correlated with the phenolic content. For the cytotoxic activity, the non-polar extracts of E. chilensis had the highest antiproliferative effect for the MCF-7 and PC-3 cancer lines; the extract was shown to be up to three times more selective than doxorubicin. However, the cytotoxic effect was not correlated with the antioxidant activity. Lastly, the GC-MS analysis showed a high concentration of saturated fatty acids (mainly n-hexadecanoic acid) and terpenoids (mainly 4-(hydroxy-ethyl)-γ-butanolactone). The cytotoxic activity and selectivity of the non-polar extracts of E. chilensis for the MCF-7 and PC-3 cell lines could be related to the terpenic compounds and fatty acids of the extracts or to the synergistic effect of all of the compounds in the extracts. These non-polar extracts can be used for the development of new drugs against breast and prostate cancer.

1 January 2013 in Journal of the Chilean Chemical Society
Verified
Journal Article
Open access
PDF file
MMMarco Mellado
Marco Mellado
AMAlejandro Madrid
Alejandro Madrid
HPHugo Peña-Cortés
Hugo Peña-Cortés
RLRodolfo López
Rodolfo López
CJCarlos Jara
Carlos Jara
LELuis Espinoza
Luis Espinoza

15 September 2018 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
MMMarco Mellado
Marco Mellado
AMAlejandro Madrid
Alejandro Madrid
MRMauricio Reyna-Jeldes
Mauricio Reyna-Jeldes
CWCaroline Weinstein-Oppenheimer
Caroline Weinstein-Oppenheimer
JMJaime Mella
Jaime Mella
MCMauricio Cuellar
Mauricio Cuellar